Download presentation
Presentation is loading. Please wait.
Published byGiada Ruggeri Modified over 5 years ago
1
Upregulated SCPs in MFS mice Upregulated SCPs in MFS patients
-log10(p) B Upregulated SCPs in MFS patients -log10(p) Supplementary Figure 1
2
A B Supplementary Figure 2 Downregulated SCPs after baclofen treatment
in CMap database – baclofen (experiment # 2036) -log10(p) B Downregulated SCPs after baclofen treatment in CMap database – baclofen (all experiments combined) -log10(p) Supplementary Figure 2
3
Supplementary Figure 3 A B Downregulated SCPs in WT mice +/- BAC
-log10(p) B Downregulated SCPs in MFS mice +/- BAC -log10(p) Supplementary Figure 3
4
Supplementary Fig. 4 A 25 50 100 75 Percent Survival 30 60 90
25 50 100 75 Percent Survival 30 60 90 Days After Birth WT VEH MFS ENA MFS VEH MFS PRO ns B 0.00 0.05 0.10 0.15 0.20 0.25 0.00 0.05 0.10 0.15 0.20 0.25 0.30 AoR Diameter (cm) AsA Diameter (cm) WT MFS MFS MFS WT MFS MFS MFS VEH VEH PRO ENA VEH VEH PRO ENA Supplementary Fig. 4
5
Supplementary Fig. 5 A B C WT VEH MFS BAC
Circumferential Stiffness (MPa) 2 4 6 8 WT VEH MFS BAC Circumferential Stress (kPa) 200 400 600 WT VEH MFS BAC Stored Elastic Energy (kPa) 50 100 150 Supplementary Fig. 5
Similar presentations
© 2024 SlidePlayer.com. Inc.
All rights reserved.